Cyclerion Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SIREN, L.L.C. | 02/13/2026 | 115.60 K | $146.82 K | -0.48% | 3.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 43.30 K | $55.01 K | 16.53% | 1.34% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 41.56 K | $52.78 K | 212.61% | 1.29% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 28.30 K | $35.94 K | 100.00% | 0.88% |
| VANGUARD GROUP INC | 01/29/2026 | 23.49 K | $29.83 K | 0.00% | 0.73% |
| BLACKROCK, INC. | 02/12/2026 | 16.80 K | $21.33 K | 0.00% | 0.52% |
| XTX TOPCO LTD | 02/17/2026 | 10.03 K | $12.73 K | 100.00% | 0.31% |
| CITIGROUP INC | 02/13/2026 | 8.20 K | $10.42 K | 100.00% | 0.25% |
| FMR LLC | 02/17/2026 | 4.74 K | $6.02 K | -0.13% | 0.15% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 3.15 K | $4.01 K | 35.48% | 0.10% |
| UBS GROUP AG | 01/29/2026 | 376 | $478 | 667.35% | 0.01% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 192 | $244 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 130 | $165 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 107 | $136 | 386.36% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 100 | $127 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/30/2026 | 100 | $127 | 0.00% | 0.00% |
| 02/05/2026 | 72 | $91 | 100.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 5 | $6 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 1 | $2 | -99.85% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclerion Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Cyclerion Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 7,353
UBS Group AG: 3,391
Activest Wealth Management: 100
CITIGROUP INC: 89
BNP PARIBAS ARBITRAGE, SNC: 5
Caitong International Asset Management Co., Ltd: 4
9.19% of Cyclerion Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 898.83 K shares in the last 24 months. This purchase volume represents approximately $1.34 M in transactions.